Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study

Martin, Thomas G.; Moreau, Philippe; Usmani, Saad Z.; Garfall, Alfred; Mateos, Maria -Victoria; San-Miguel, Jesus F.; Oriol, Albert; Nooka, Ajay K.; Rosinol, Laura; Chari, Ajai; Karlin, Lionel; Krishnan, Amrita; Bahlis, Nizar; Popat, Rakesh; Besemer, Britta; Martinez-Lopez, Joaquin; Delforge, Michel; Trancucci, Danielle; Pei, Lixia; Kobos, Rachel; Fastenau, John; Gries, Katharine S.; van de Donk, Niels W. C. J.

Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study

Autor(en):

Martin, Thomas G.; Moreau, Philippe; Usmani, Saad Z.; Garfall, Alfred; Mateos, Maria -Victoria; San-Miguel, Jesus F.; Oriol, Albert; Nooka, Ajay K.; Rosinol, Laura; Chari, Ajai; Karlin, Lionel; Krishnan, Amrita; Bahlis, Nizar; Popat, Rakesh; Besemer, Britta; Martinez-Lopez, Joaquin; Delforge, Michel; Trancucci, Danielle; Pei, Lixia; Kobos, Rachel; Fastenau, John; Gries, Katharine S.; van de Donk, Niels W. C. J.

Tübinger Autor(en):

Besemer, Britta

Erschienen in:

Clinical Lymphoma Myeloma & Leukemia (2024), Bd. 24, H. 3, S. 194-202

Verlagsangabe:

Dallas : Cig Media Group, Lp

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.clml.2023.11.001

ISSN:

2152-2650